FDA Adverse Event Injury Summary report: N

UNK GEL BREAST IMPLANT

MDR report key: 16877374 · Received May 5, 2023

Report

Report Number
9617229-2023-06985
Event Type
Injury
Date Received
May 5, 2023
Date of Event
April 11, 2023
Report Date
May 5, 2023
Manufacturer
ALLERGAN (COSTA RICA)
Product Code
FTR
PMA / PMN Number
P020056
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

ARTICLE CITATION: HADAD, E., SUALHI, I., LEGARDA, C., SELIGMAN, Y., SORKIN, A., DOR, O., MENASHE, S., HELLER, L., & WISER, I. (2023). "SILICONE BREAST IMPLANT RUPTURE IS MORE PREVALENT IN THE DOMINANT LIMB SIDE, A RETROSPECTIVE COHORT STUDY". JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 80(2023), P.126-132. HTTPS://DOI.ORG/10.1016/J.BJPS.2023.02.016. CORRESPONDENCE CONTACT: DR. (B)(6). DEPARTMENT OF PLASTIC SURGERY. (B)(6) MEDICAL CENTER. (B)(6) ISRAEL. EMAIL: (B)(6). ADDITIONAL CONTRIBUTING DOCTORS: (B)(6). THE EVENT OF CAPSULAR CONTRACTURE IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT. FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. REASON FOR REOPERATION: RUPTURE, CAPSULAR CONTRACTURE BAKER GRADE UNKNOWN.

Description of Event or Problem · 0

HEALTHCARE PROFESSIONAL REPORTED THROUGH THE JOURNAL ARTICLE " SILICONE BREAST IMPLANT RUPTURE IS MORE PREVALENT IN THE DOMINANT LIMB SIDE, A RETROSPECTIVE COHORT STUDY. JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY." THAT PATIENTS ARE MORE LIKELY TO EXPERIENCE RUPTURE OR CAPSULAR CONTRACTURE (BAKER GRADE UNKNOWN) FOR BREAST IMPLANT DEVICES IS MORE PREVALENT IN THE DOMINANT LIMB SIDE. THE DEVICES HAVE BEEN EXPLANTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1678227 UNK GEL BREAST IMPLANT PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED FTR ALLERGAN (COSTA RICA) NI

Patients

Seq Age Sex Outcome Treatment
1 Female Required Intervention